If this message is not displayed correctly, click here.



No 155, September 2018


Editor in Chief: María José Soler Romeo - Editorial Secretariat: Valentina Cocchi
Newsletter Design: Ilaria Martini

ERA-EDTA Headquarters - Via XXIV Maggio, 38 - 43123 Parma - Italy


Do not miss the chance to contribute to ERA-EDTA Educational Sessions in Europe

DESCARTES Working Group invites specialists in nephrology and transplantation to submit an abstract on kidney transplantation (any topic) following the NDT format instructions: max. 250~300 words (excl. names and affiliations); four paragraphs entitled ‘Background', `Methods', `Results' and `Conclusions'.

Submission must be made via email to descartes@era-edta.org.

The deadline for abstract submissions is September 29, 2018.

The authors of the three best abstracts will be invited to present their work in a plenary session at ‘Making the right decision in kidney transplantation: current controversies on clinical and ethical issues’ an educational event tailor-made for trainees and young specialists in nephrology and transplantation to be held at the John McIntyre Conference Centre in Edinburgh (UK) on October 12, 2018.
Click here for more details.

ERN and Diabesity Working Groups invite specialists in nephrology, nutrition and diabetes to submit abstracts on the occasion of the educational meeting ‘Cross talks between diabetes, obesity and nutrition in renal disease’ to be held in Paris (France) on November 8-9, 2018.

Communications should address all aspects of nutrition and diabetes.
All abstracts must be submitted to workinggroups@era-edta.org by September 23, 2018.

The authors of the three best scored abstracts will be asked to present their work in a free communication session.

Click here for more details.


Rare Kidney Disease Webinars
The ERA-EDTA Working Group on Inherited Kidney Diseases (WGIKD) and ERKNet, the European Reference Network for Rare Kidney Diseases are happy to present Rare Kidney Disease Webinars, an educational initiative that is freely accessible to all users.

A new Webinar will be held on TUESDAY, September 18, 2018 at 4:00-5:00 pm CET (3:00 pm UK time, 5:00 pm Eastern European time).
Marius Miglinas (University Hospital Vilnius) will present on ‘A spectrum of complement-mediated thrombotic microangiopathies after kidney transplantation'.
Register here, to receive the access link to the Webinar.
Please pay attention to the technical requirements provided with the access link.

If you would like to be notified automatically about future Rare Kidney Disease Webinars, please sign up here for the ERKNet Newsletter.
You can find the schedule for upcoming Webinars and past presentations at www.erknet.org under the ‘Education & Training’ tab.
ERA-EDTA 2018 industry symposia
Learn more about the importance of understanding CKD-MBD and recent advances in pathophysiology and management of this disease from the webcasts of two ERA-EDTA 2018 industry symposia
During the 55th ERA-EDTA Congress 2018 in Copenhagen, the following two industry symposia about CKD-MBD supported by Vifor Fresenius Medical Care Renal Pharma and Amgen were presented:

  1. The evolving face of CKD-MBD: Can an increased understanding lead to improvements in treatment? (Supported by Vifor Fresenius Medical Care Renal Pharma)
    Topics: “Understanding the complexity of CKD-MBD”, “Using our understanding of the evolution of SHPT to choose the right target at the right time” and “Balancing theoretical targets with practical considerations for phosphate management”. 
    Find the webcasts on the ENP here.

  2. Recent advances in pathophysiology and management of CKD-MBD (Supported by Amgen)
    Topics: “New insights into the role of FGF-23 in CKD-MBD and beyond”, and “Management of secondary hyperparathyroidism with injectable etelcalcetide”.
    Find the webcasts on the ENP here.

    You can find all available industry symposia in addition to other topics on the ENP here.
Keen in getting involved in Incremental Haemodialysis?
Why not take the survey created by Prof. C. Basile (EUDIAL Chair) - it is available here
The majority of patients on dialysis are currently treated with a fixed dose thrice-weekly haemodialysis regimen irrespective of whether or not they are starting dialysis therapy (incident) or have been receiving dialysis for some time (prevalent) and without consideration for their residual kidney function (RKF). The thrice-weekly regimen has been assumed almost as a dogma in the dialysis community. Incredibly, this schedule has been widely accepted worldwide without ever undergoing any randomised controlled trial to examine whether less frequent haemodialysis treatments would be inadequate or harmful.

Read more→
NDT - Article of the week
Pathophysiology of renal anaemia
Anemia is a long-standing side-effect of kidney diseases. The discovery, synthesis and administration of recombinant erythropoietin has considerably improved symptoms, but many other defects are still present, such as impaired iron metabolism and resistance to EPO, which confirms that there are still unmet needs in the field.
The paper is accessible here free of charge until this Sunday at 23.59 (UK time)
Do not miss it!

New from NDT: Author videos

Watch the latest author videos from NDT – ‘The association of interdialytic blood pressure variability with cardiovascular events and mortality in hemodialysis patients’ by Pantelis A. Sarafidis.
Watch the video here and read the article here.
Click here to see all of the NDT author videos.

Contact Us
Web Site



Working Groups

...and their latest initiatives:




The advantages of being a member of ERA-EDTA

As a member you will become part of one of the
most influential European Medical Associations!


The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003.